B of A Securities Maintains Buy on Bristol-Myers Squibb, Lowers Price Target to $66

B of A Securities analyst Tim Anderson maintains Bristol-Myers Squibb (NYSE:BMY) with a Buy and lowers the price target from $67 to $66.